Nevrargenics Ltd is a UK-based neuroscience company specialising in the discovery and development of novel medicines for the treatment of neurodegenerative disease, such as Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer’s, Parkinson’s, Multiple Sclerosis and other neurological diseases as well as application in other conditions such as liver diseases and eye diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Durham, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://nevrargenics.com/
- Keywords
- Pharmaceuticals, Drug Discovery, Drug Development, Neurodegeneration, Neurology, Diseases, R&D, Alzheimer's, Parkinson's, Multiple Sclerosis, ALS, MND, Motor Neuron Disease, Innovation, Medicines, Novel, Biotech, UK.
- HQ
- Durham
Nevrargenics Ltd. Questions
Nevrargenics Ltd.'s website is https://nevrargenics.com/
Nevrargenics Ltd.'s LinkedIn profile is https://uk.linkedin.com/company/nevrargenics
Nevrargenics Ltd. has
6 employees.
View email and phone details for 6
employees at Nevrargenics Ltd..
Nevrargenics Ltd.'s industry is
Biotechnology Research
Nevrargenics Ltd.'s top competitors are
Sundara Pharma,
Marrabio,
Neurobio,
Genben,
Lightox Ltd,
2n Pharma,
Centre For Pharmaceutical Medicine Research, King's College London,
Biogen,
Nrg Therapeutics,
Aviadobio.
Nevrargenics Ltd.'s categories are Biotechnology Research
Nevrargenics Ltd.'s founding year is 2019
